Roche sees sales drop on lower demand for COVID-19 tests, but backs view

The Swiss pharma major reported sales of 15.32 billion euros ($16.82 billion) for the first quarter, down from CHF16.45 billion in the same quarter a year prior.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.